Draig bags another $65M to speed testing of brain drugs
Draig bags another $65M to speed testing of brain drugs
Draig Therapeutics
Private
Next-Generation Therapies for Major Neuropsychiatric Disorders
Company Info
Recent News
Draig nets $65M to advance depression drug aimed at rebuilding synapses
Draig raises $65M to advance a depression drug aimed at rebuilding synapses.
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer